Clincial Trials match your criteria
-
Airway microbiome, nasal microRNA, and age 6-year asthma phenotypes in the MARC-35 cohort.
Airway microbiome, nasal microRNA, and age 6-year asthma phenotypes in the MARC-35 cohort.
-
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial (enliGHten)
-
Continuation Study With Budesonide Oral Suspension for Adolescent and Adults
A Phase 3, Multicenter, Open-label Continuation Study with Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects with Eosinophilic Esophagitis (EoE)
-
Medial Epicondyle Fractures
Non-Operative Treatment Compared with Internal Fixation for Displaced Medial Humeral Epicondyle Fractures: A Multicenter Prospective Evaluation
-
Late Effects After Tx for High-Risk Neuroblastoma
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
-
Tx for Recurrent/Refractory/Newly Dxd Sarcomas,Wilms,Rare Tumors
Phase 2 Trial of XL184 (Cabozantinib) an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults with Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors
-
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due
BOTOX® in the Treatment of Urinary Incontinence Due to Overactive Bladder in Patients 12 to 17 Years of Age
-
Surveillance or Treatment of Patients w/Germ Cell Tumors
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors
-
Phase 3 Randomized study for Refractory Melanoma
A Randomized Phase 3 Comparison of IMO-2125 with Ipilimumab versus Ipilimumab Alone in Subjects with Anti-PD-1 Refractory Melanoma
-
Imatinib & Combo Chemo in Treating Pts w/newly diagnosed Ph+ ALL
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
